Drugs / rMenB+OMV NZ
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00721396 | Aug 2008 → Jul 2010 | meningococcal infection | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rMenB+OMV NZ | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00721396 ↗ |
| Known as | 4CMenB | “To determine the immunogenicity and reactogenicity of a multicomponent MenB vaccine (4CMenB) and routine infant vaccines when given either concomitantly or separately.” PMID 22318278 ↗ Feb 2012 |
| Modality | Vaccine | “rMenB+OMV NZ vaccine at 2, 4, and 6 months of age” NCT00721396 ↗ |